The gastroesophageal cancer drug market
Paul Wilcock, Rachel M. Webster
Index: 10.1038/nrd.2018.35
Full Text: HTML
Abstract
The gastroesophageal cancer drug market The gastroesophageal cancer drug market, Published online: 03 April 2018; doi:10.1038/nrd.2018.35Immune checkpoint inhibitors are forecast to expand the market for gastroesophageal cancer drugs, which is particularly large in Asia.
Latest Articles:
INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology
2018-04-06
[10.1038/nrd.2018.34]
Antivirals: Topical therapy for ocular herpes
2018-03-28
[10.1038/nrd.2018.47]
Infectious disease: Virus-based tuberculosis vaccine
2018-03-28
[10.1038/nrd.2018.50]
Immunotherapy: iPSC-based cancer vaccine
2018-03-28
[10.1038/nrd.2018.48]
2018-03-28
[10.1038/nrd.2018.41]